Guardant Health earnings

Guardant Health (NASDAQ:GH):

Q4 GAAP EPS of -$0.30 beats by $0.05.

Revenue of $32.87M (+64.3% Y/Y) beats by $6.99M.

https://seekingalpha.com/news/3442056-guardant-health-beats-…

Obviously this is a company that is about what’s too come (FDA approval, reimbursement approvals,widespread adoption of it biomarker assay for numerous cancers, prophylactic pre screening, post disease ID follow-up, etc…) , more than what’s recently happened, but at this point things look pretty good and the future is quite bright…

https://www.fool.com/investing/2019/03/12/why-guardant-healt…

6 Likes